Research Article
Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis
| Prior medication | Teriflunomide (%) | Glatiramer acetate (%) |
| Cyclophosphamide | 6 (20.7) | 2 (6.7) | Dimethyl fumarate | 8 (27.6) | 5 (16.7) | Fingolimod | 2 (6.9) | 0 (0) | Glatiramer acetate | 2 (6.9) | 2 (6.7) | Interferon beta-1a IM | 1 (3.4) | 5 (16.7) | Interferon beta-1a SC | 1 (3.4) | 3 (10.0) | Methotrexate | 0 (0) | 2 (6.7) | Methylprednisolone IV | 2 (6.9) | 1 (3.3) | Mycophenolate | 1 (3.4) | 0 (0) | Natalizumab | 2 (6.9) | 2 (6.7) | None | 2 (6.9) | 7 (23.3) | Riluzole | 1 (3.4) | 0 (0) | Riluzole and interferon beta-1a SC | 0 (0) | 1 (3.3) | Rituximab | 1 (3.4) | 0 (0) |
|
|
IM: intramuscularly; SC: subcutaneously; IV: intravenously; : number of subjects. |